| Interpretive Data: |
A post-immunization antibody concentration of 1.30 µg/mL or greater indicates adequate immune response. When comparing to pre-immunization concentrations that are 1.30 µg/mL or greater, a fourfold or greater increase in post-immunization concentration indicates adequate response; however, a high pre-immunization antibody concentration may preclude a fourfold increase.
Indication of immune system competence is demonstrated by an adequate immune response to at least 50 percent of the serotypes included in the vaccine challenge.
See Compliance Statement B: www.aruplab.com/CS
|
| Note: |
Includes Serotypes 2, 8, 9N, 10A, 11A, 12F, 15B, 17F, 20, 22F, and 33F
This test is designed to use both pre- and post-immunization specimens to assess immune responsiveness to pneumococcal vaccine. This test is not designed to determine protection to Streptococcus pneumoniae based on a single specimen.
|
| CPT Code(s): |
86317 X 11
|
|
![[ image for: Additional Technical Information]](icon_227.jpg){kind=icon}